Recently, the University of Oxford in the United Kingdom started a first phase clinical trial of a new HIV vaccine candidate in the United Kingdom. The trial, called HIV-CORE 0052, aims toRead More…
Nature: The protective effect of mRNA vaccine BNT162b2 against COVID-19 variant may be weakened
At present, a large-scale vaccination of COVID-19 is carrying out around the world, bringing hope for alleviating the epidemic situation of COVID-19’s. However, due to the menacing invasion of various SARS-CoV-2 variantsRead More…
Dengue Vaccine! Tetravalent Vaccine TAK-003 Enters Review in EU
Takeda Pharmaceutical recently announced that the European Drug Administration (EMA) has accepted the declaration of its dengue vaccine TAK-003, which is developed for people between the ages of 4 and 60 toRead More…
PD-1 Antibodies Bring Clinical Development of Neoantigen Vaccines to the Fore – New Nature’s Report
At present, new antigen vaccines have become a hot direction in the field of cancer immunotherapy. With the release of some positive clinical data and more and more projects entering the clinicalRead More…
Expert Review of Vaccines: virus vaccine is safe for immunodeficient children
Inactivated and live attenuated vaccines usually produce sufficient immune responses and can be safely used in children with autoimmune diseases received all treated except the most effective immunosuppressants, according to a reviewRead More…
Protein Language Model: Laying the Foundation for General Vaccine
One of the reasons why it is so difficult to make effective vaccines against certain viruses, including influenza and HIV, is that these viruses mutate very quickly. This allows them to escapeRead More…
Super Vaccine for Cancer–Galinpepimut-S Combined with Checkpoint Inhibitors
Recently, the clinical data on the treatment of two different types of WT1-positive (WT1+) advanced solid tumors with a new cancer vaccine galinpepimut-S (GPS) combined with immune checkpoint inhibitors were released. GPSRead More…
RSV Vaccine R&D: Advancing in a Rocky Path with Hope
Respiratory syncytial virus (RSV) is the most common pathogen of viral pneumonia in children, which occurs mostly in newborns and infants less than 6 months old, as well as in immunodeficiency patientsRead More…
Analysis of Vaccine Reviews-Episode II
1. Type of vaccine Advances in virology, molecular biology, and immunology have created many alternatives to traditional vaccines. Modern vaccines include nucleic acid (mRNA, DNA) vaccines, viral vector vaccines, virus-like particles andRead More…
Analysis of Vaccine Reviews-Episode I
Vaccines can greatly prevent infectious diseases. Between 1924 and 2010, 103 million childhood diseases were prevented in the United States through vaccination alone. In particular, smallpox was eliminated by vaccines in 1980,Read More…